{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:19:09Z","timestamp":1768713549432,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jgar.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T20:07:04Z","timestamp":1424894824000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Resistance to antimalarial drugs: An endless world war against Plasmodium that we risk losing"],"prefix":"10.1016","volume":"3","author":[{"given":"Carlo","family":"Severini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Menegon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2015.02.002_bib0360","series-title":"World malaria report 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jgar.2015.02.002_bib0365","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The Global Burden of Disease Study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-3305-3-5","article-title":"History of the discovery of the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.jgar.2015.02.002_bib0375","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(04)15836-4","article-title":"A large focus of naturally acquired Plasmodium knowlesi infections in human beings","volume":"363","author":"Singh","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2015.02.002_bib0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.actatropica.2012.10.008","article-title":"Plasmodium knowlesi: the emerging zoonotic malaria parasite","volume":"125","author":"Antinori","year":"2013","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2015.02.002_bib0385","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/1475-2875-13-422","article-title":"Severe Plasmodium knowlesi infection with multi-organ failure imported to Germany from Thailand\/Myanmar","volume":"13","author":"Seilmaier","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2015.02.002_bib0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/asheducation-2002.1.35","article-title":"Malaria and the red cell","author":"Weatherall","year":"2002","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jgar.2015.02.002_bib0395","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid1101.040519","article-title":"Plasmodium vivax malaria","volume":"11","author":"Kochar","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0400","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.trstmh.2007.02.014","article-title":"Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature","volume":"101","author":"Price","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0405","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1179\/1465328111Y.0000000040","article-title":"Clinical profiles of 13 children with Plasmodium vivax cerebral malaria","volume":"31","author":"Tanwar","year":"2011","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.jgar.2015.02.002_bib0410","first-page":"609","article-title":"Plasmodium vivax malaria\u2014is it really benign?","volume":"111","author":"Saini","year":"2013","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.jgar.2015.02.002_bib0415","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/654815","article-title":"On the cytoadhesion of Plasmodium vivax-infected erythrocytes","volume":"202","author":"Carvalho","year":"2010","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2015.02.002_bib0420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0074-02762011000900010","article-title":"On cytoadhesion of Plasmodium vivax: raison d\u2019\u00eatre?","volume":"106","author":"Costa","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2015.02.002_bib0425","doi-asserted-by":"crossref","first-page":"e34509","DOI":"10.1371\/journal.pone.0034509","article-title":"Plasmodium vivax adherence to placental glycosaminoglycans","volume":"7","author":"Chotivanich","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2015.02.002_bib0430","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0435","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pt.2013.05.005","article-title":"Artemisinin resistance is a clear and present danger","volume":"29","author":"Dondorp","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","article-title":"Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents","volume":"79","author":"Foley","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jgar.2015.02.002_bib0445","series-title":"Antimalarial agents: chemistry and pharmacology","author":"Thompson","year":"1972"},{"key":"10.1016\/j.jgar.2015.02.002_bib0450","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","article-title":"The global distribution and population at risk of malaria: past, present, and future","volume":"4","author":"Hay","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0455","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0074-02761910000100009","article-title":"Forma\u00e7\u00e3o de ra\u00e7a do hematozoario do impaludismo rezistente \u00e0 quinina","volume":"2","author":"Neiva","year":"1910","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2015.02.002_bib0460","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(65)90395-8","article-title":"Chloroquine-resistant falciparum malaria in Thailand","volume":"2","author":"Harinasuta","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2015.02.002_bib0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.1961.10.5","article-title":"Observations on two Plasmodium falciparum infections with abnormal response to chloroquine","volume":"10","author":"Moore","year":"1961","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0470","first-page":"184","article-title":"Chloroquine resistant malaria in Papua New Guinea","volume":"19","author":"Grimmond","year":"1976","journal-title":"PNG Med J"},{"key":"10.1016\/j.jgar.2015.02.002_bib0475","first-page":"463","article-title":"Chloroquine-resistant malaria acquired in Kenya and Tanzania\u2014Denmark, Georgia, New York","volume":"27","author":"Centers for Disease Control (CDC)","year":"1978","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jgar.2015.02.002_bib0480","first-page":"328","article-title":"Revised recommendations for malaria chemoprophylaxis for travelers to East Africa","volume":"31","author":"Centers for Disease Control (CDC)","year":"1982","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jgar.2015.02.002_bib0485","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","article-title":"The public health impact of chloroquine resistance in Africa","volume":"64","author":"Trape","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CMR.17.1.235-254.2004","article-title":"History, dynamics, and public health importance of malaria parasite resistance","volume":"17","author":"Talisuna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2015.02.002_bib0495","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","article-title":"phospholipids, and the antimalarial actions of quinoline drugs","volume":"74","author":"Fitch","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jgar.2015.02.002_bib0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbiopara.2007.11.005","article-title":"Haemozoin formation","volume":"157","author":"Egan","year":"2008","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0505","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jgar.2015.02.002_bib0510","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.jgar.2015.02.002_bib0515","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jgar.2015.02.002_bib0520","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.00089-08","article-title":"Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum","volume":"52","author":"Mehlotra","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0525","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","article-title":"Contribution of the pfmdr1 gene to antimalarial drug resistance","volume":"94","author":"Duraisingh","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2015.02.002_bib0530","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01243-08","article-title":"Plasmodium falciparum Na+\/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine","volume":"53","author":"Henry","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0535","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molbiopara.2009.01.011","article-title":"Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium\u2013proton exchanger PfNHE","volume":"165","author":"Nkrumah","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0540","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2015.02.002_bib0545","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0550","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QCO.0b013e32834c61e3","article-title":"Plasmodium vivax treatments: what are we looking for?","volume":"24","author":"Price","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0555","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0560","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4269\/ajtmh.2008.78.736","article-title":"High-dose primaquine regimens against relapse of Plasmodium vivax malaria","volume":"78","author":"Krudsood","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0565","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2217\/fmb.10.136","article-title":"Antimalarial drugs: modes of action and mechanisms of parasite resistance","volume":"5","author":"M\u00fcller","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0570","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jgar.2015.02.002_bib0575","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.trstmh.2008.01.003","article-title":"Antifolate resistance in Africa and the 164-dollar question","volume":"102","author":"Hyde","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0580","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1475-2875-10-283","article-title":"In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum","volume":"10","author":"Andriantsoanirina","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2015.02.002_bib0585","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/AAC.00091-09","article-title":"Polymorphism in PfRPM1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine\u2013pyrimethamine treatment","volume":"53","author":"Dahlstrom","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0590","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","article-title":"Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite","volume":"272","author":"Srivastava","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2015.02.002_bib0595","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites","volume":"33","author":"Srivastava","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0600","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0605","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1475-2875-7-240","article-title":"Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone\u2013proguanil","volume":"7","author":"Sutherland","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2015.02.002_bib0610","series-title":"Antimalarial drug combination therapy. Report of a WHO technical consultation","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.jgar.2015.02.002_bib0615","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1471-4922(00)01838-9","article-title":"Possible modes of action of the artemisinin-type compounds","volume":"17","author":"Olliaro","year":"2001","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0620","first-page":"3","article-title":"Quinolines and artemisinin: chemistry, biology and history","volume":"295","author":"Bray","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jgar.2015.02.002_bib0625","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2015.02.002_bib0630","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0635","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2015.02.002_bib0640","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","article-title":"Plasmodium vivax resistance to chloroquine?","volume":"2","author":"Rieckman","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2015.02.002_bib0645","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of Plasmodium vivax malaria","volume":"64","author":"Mendis","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2015.02.002_bib0650","doi-asserted-by":"crossref","first-page":"e1089","DOI":"10.1371\/journal.pone.0001089","article-title":"Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms","volume":"2","author":"Suwanarusk","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2015.02.002_bib0655","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/592451","article-title":"Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax","volume":"198","author":"Suwanarusk","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0660","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"Russell","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0665","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.45.11.3122-3127.2001","article-title":"Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine\u2013pyrimethamine: geographical and clinical correlates","volume":"45","author":"Imwong","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0670","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/AAC.47.5.1514-1521.2003","article-title":"Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure","volume":"47","author":"Imwong","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0675","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/AAC.48.6.2214-2222.2004","article-title":"Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site","volume":"48","author":"Korsinczky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0680","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.01200-06","article-title":"Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum","volume":"51","author":"Alam","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.02.002_bib0685","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1475-2875-13-286","article-title":"The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion","volume":"13","author":"Smith Gueye","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2015.02.002_bib0690","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2015.02.002_bib0695","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3201\/eid2007.140155","article-title":"Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam","volume":"20","author":"Van Hong","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2015.02.002_bib0700","series-title":"Malaria","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.jgar.2015.02.002_bib0705","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2015.02.002_bib0710","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(14)60656-5","article-title":"Malaria: a molecular marker of artemisinin resistance","volume":"383","author":"White","year":"2014","journal-title":"Lancet"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716515000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716515000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:49Z","timestamp":1761990769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716515000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213716515000119"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2015.02.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to antimalarial drugs: An endless world war against Plasmodium that we risk losing","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}